Who we are now
Our ambitions grow with our successes
Here at Luye Pharma UK, we are dedicated to using our specialist knowledge of central nervous system (CNS) medicines to further develop new solutions and expand our product portfolio. We have a genuine long-term commitment to achieving better outcomes for patients, so we are growing our front-leading solutions across a range of disease areas, while carefully and selectively expanding the business via partnerships, and the acquisition of further products for distribution to the UK.
The full Luye story
Supported by our heritage
Luye Pharma Group, a member of Luye Life Sciences Group, a Hong Kong-listed company is an international pharmaceutical company with a focus on targeting central nervous system (CNS), oncology and cardiovascular. Global R&D, global manufacturing, and the global sale of innovative medications are the company’s three main strategic priorities.
Being part of this longstanding heritage means that we have the resources and capabilities to continuously improve our manufacturing, distribution, cost efficiencies and support to the benefit of healthcare professionals and their patients. We thrive on a genuine passion for providing patients with better solutions. Working together with our numerous established partnerships, and with our Swiss and German manufacturing capabilities, this has given us a unique position to effectively use our distribution and manufacturing channels to deliver solutions throughout the UK.
Our growth and acquisitions
Luye Pharma’s timeline of growth
In 2016 Luye Pharma Group acquired the transdermal drug delivery system business from the Swiss pharmaceutical company Acino, expanding operations to major international markets including Europe, the U.S. and Japan.
Growth continued in 2018 with the acquisition of AstraZeneca’s Seroquel® and Seroquel XR® (quetiapine) in 51 countries and regions.
In July 2019 Luye UK was established and began distributing a portfolio of drugs. The company has a forecast of planned sustainable and scalable growth in line with its business strategy.
Below highlights some of the scheduled product launches with others being announced soon.
We are looking to expand our portfolio
For more information on licence acquisition and what it means to partner with Luye Pharma UK, click below.
Find out moreHow we work
Culture
Integrity
To never lose sight that every activity we undertake should be focused on better patient outcomes.
Collaboration
With anyone working in or effected by the patient journey.
Knowledge
A business with people that have in-depth technical knowledge that empowers informed choice.
Quality
By the continued investment in innovation, systems, processes and most importantly our people.
Reliability
A reputation for reliability, trust and credibility, supported by the dedicated, expertise of our UK management team.
Investment
We invest in people, ensuring they are knowledgeable, competent, and empowered.
